Amyloid β peptides stimulate tissue-type plasminogen activator but not recombinant prourokinase

Thrombosis Research

Volumn 85, Issue 3, 1997, Pages 217-224

  Wnendt, Stephan ^a   Wetzels, Ingrid ^a   Günzler, Wolfgang A ^a  

^a GRÜNENTHAL GMBH   (Germany)

Author keywords

acute myocardial infarction; amyloid peptides; haemorrhagic stroke; thrombolysis

Indexed keywords

AMYLOID BETA PROTEIN; DEXTRO VALYLLEUCYLLYSINE 4 NITROANILIDE; SARUPLASE; TISSUE PLASMINOGEN ACTIVATOR; TRANEXAMIC ACID; UNCLASSIFIED DRUG; UROKINASE;

ARTICLE; CONTROLLED STUDY; FIBRINOLYSIS; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL;

AMYLOID BETA-PROTEIN; ANTIFIBRINOLYTIC AGENTS; CHROMOGENIC COMPOUNDS; DEPRESSION, CHEMICAL; HUMANS; HYDROLYSIS; RECOMBINANT PROTEINS; TISSUE PLASMINOGEN ACTIVATOR; TRANEXAMIC ACID; URINARY PLASMINOGEN ACTIVATOR;

EID: 0031079734     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(97)00006-6     Document Type: Article

References (16)

1. GORE J.M., GRANGER C.B., SIMOONS M.L., SLOAN M.A., WEAVER D., WHITE H.D., BARBASH G.I., VAN DE WERF F., AYLWARD P.E., TOPOL E.J., CALIFF R.M. Stoke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Circulation. 92:1995;2811-2818.
2. DE VRIES C., VEERMAN H., PANNEKOEK H. Identification of the domains of tissue-type plasminogen activator involved in augmented binding to fibrin after limited digestion with plasmin. J. Biol. Chem. 264:1989;12604-12610.
3. ZAMARRON C., LIJNEN H.R., COLLEN D. Kinetics of the activation of plasminogen by natural and recombinant tissue-type plasminogen activator. J. Biol. Chem. 259:1984;2080-2083.
4. KINGSTON I.B., CASTRO M.J.M., ANDERSON S. In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid β-peptide analogues. Nature Medicine. 1:1995;138-142.
5. SLOAN M.A., PRICE T.R., PETITO C.K., RANDALL A.M.Y., SOLOMON R.E., TERRIN M.L., GORE J., COLLEN D., KLEIMAN N., FEIT F., BABB J., HERMAN M., ROBERTS W.C., SOPKO G., BOVILL E., FORMAN S., KNATTERUD G.L. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: The Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience. Neurology. 45:1995;649-658.
6. SELKOE D.J. Normal and abnormal biology of the β-amyloid precursor protein. Ann. Rev. Neurosci. 17:1994;489-517.
7. SEUBERT P., VIGO-PELFREY C., ESCH F., LEE M., DOVEY H., DAVIS D., SINHA S., SCHLOSSMACHER M., WHALEY J., SWINDLEHURST C., MCCORMACK R., WOLFERT R., SELKOE D., LIEBERBURG I., SCHENK D. Isolation and quantification of soluble Alzheimer's beta peptide from biological fluids. Nature. 329:1992;325-327.
8. FLEURY V., LIJNEN H.R., ANGLES-CANO E. Mechanism of the enhanced intrinsic activity of single-chain urokinase-type plasminogen activator during ongoing fibrinolysis. J. Biol. Chem. 268:1993;18554-18559.
9. WU H.-L., CHANG B.-I., WU D.-H., CHANG L.-C., GONG C.-C., LOU K.-L., SHI G.-Y. Interaction of plasminogen and fibrin in plasminogen activation. J. Biol. Chem. 265:1990;19658-19664.
10. ADAMS LUCAS M., FRETTO L.J., McKee P.A. The binding of human plasminogen to fibrin and fibrinogen. J. Biol. Chem. 258:1983;4249-4256.
11. Effects of alteplase and saruplase on hemostatic variables: a single-blind, randomized, trial in patients with acute myocardial infarction. Coronary Artery Dis. 2:1991;349-355.
12. Early patency and reocclusion in acute myocardial infarction. A comparison between the thrombolytic agents saruplase and alteplase. Results of the SESAM trial (abstract). J. A. Coll. Cardiol. 23:((Suppl.)):1994;345A.
13. PÂQUES E.-P. Recent advances in the biochemistry of the fibrinolytic system. Behring Inst. Mitt. 82:1988;68-81.
14. GUREVICH V., LIU J.-N., PANNELL R. The intrinsic lysis concept. Ann. N. Y. Acad. Sci. 667:1992;224-232.
15. ANDREASEN P.A., PETERSEN L.C., Dan K. Diversity in catalytic properties of single chain and two chain tissue-type plasminogen activator. Fibrinolysis. 5:1991;207-215.
16. BAKKER A.H.F., WEENING-VERHOEFF E.J.D., VERHEIJEN J.H. The role of the lysyl binding site of tissue-type plasminogen activator in the interaction with a forming fibrin clot. J. Biol. Chem. 270:1995;12355-12360.